Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4524557
Max Phase: Preclinical
Molecular Formula: C35H50N6O5S
Molecular Weight: 666.89
Molecule Type: Unknown
Associated Items:
ID: ALA4524557
Max Phase: Preclinical
Molecular Formula: C35H50N6O5S
Molecular Weight: 666.89
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=C[C@]1(C)C[C@@H](OC(=O)CSc2nc(NC(=O)CN3CCN(C)CC3)c3cc[nH]c3n2)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O
Standard InChI: InChI=1S/C35H50N6O5S/c1-7-33(4)18-25(34(5)21(2)8-11-35(22(3)29(33)45)12-9-24(42)28(34)35)46-27(44)20-47-32-38-30-23(10-13-36-30)31(39-32)37-26(43)19-41-16-14-40(6)15-17-41/h7,10,13,21-22,25,28-29,45H,1,8-9,11-12,14-20H2,2-6H3,(H2,36,37,38,39,43)/t21-,22+,25-,28+,29+,33-,34+,35+/m1/s1
Standard InChI Key: LPVYOTCPAHJHMS-FFZDHKNGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 666.89 | Molecular Weight (Monoisotopic): 666.3563 | AlogP: 4.14 | #Rotatable Bonds: 8 |
Polar Surface Area: 140.75 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 10.47 | CX Basic pKa: 7.19 | CX LogP: 4.20 | CX LogD: 3.98 |
Aromatic Rings: 2 | Heavy Atoms: 47 | QED Weighted: 0.16 | Np Likeness Score: 0.35 |
1. Deng Y, Wang XZ, Huang SH, Li CH.. (2019) Antibacterial activity evaluation of synthetic novel pleuromutilin derivatives in vitro and in experimental infection mice., 162 [PMID:30445267] [10.1016/j.ejmech.2018.11.006] |
Source(1):